NCT06718764 · RECRUITING
Neurosteer Bedside Monitoring System
This study tests a forehead sensor that reads brain waves (EEG) to track delirium, sedation, and agitation in sedated ICU patients on breathing machines. Researchers check whether its readings match the standard bedside scales nurses use. It is a device study with no phase, so it measures how well the tool works, not a treatment.
You may qualify if
- Provision of signed and dated informed consent form from patient and/or LAR, including stated willingness to comply with all study procedures and availability for the duration of the study
- Any assigned sex at birth, including individuals who are transgender or intersex
- Age 18 years or older
- Mechanically ventilated patients with an anticipated LOS >/=48 hours on any sedative drips including propofol, midazolam, dexmedetomidine, fentanyl, dialudid, ketamine
You're excluded if
- Has known hearing problems and usage of hearing aids
- Has a rash on forehead
- History of polysubstance abuse
- Severe dementia
- Anticipated Withdrawing Life-Sustaining Therapy (WLST) within the next 24-48 hours
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-09-28